SlideShare a Scribd company logo
1 of 19
Clinical Pharmacy
 Prepared By:-Ms.Mali Sunayana
 Asst.Professor
 Sahyadri College of Pharmacy,
Methwade
The pharmacy services can be broadly classified as
clinical, hospital and community pharmacy services based
on the point of service.
The clinical pharmacy servicesare rendered in a clinic for
inpatients and OPD patients.
The inpatient services comprise of entire patient careand
supplies regarding the aspects involving drugs.
For example the activities like ward rounds ,safety,drug
information services, poison centre, pharmacovigilance
services, development and management of hospital
formulary, patient counseling and education along with
discharge medication.
Ward round participation
Ward rounds are the routine clinical roundswhere
the healthcare providers visit the patients in the
ward to assess the progress of the health
condition of the inpatients.
The doctor led ward rounds comprises of the unit
of medicine or any other specialty where in
professor,associate professors, assistant
professors, senior residents, postgraduates and
interns along with pharmacists and nurses observe
the patient's condition nda assess to decide further
therapeutics for the patients.
The goal of the ward round is to closely monitor the
patient's condition and take immediate intervention
to improve the patient condition and avoid death.
The doctors are visiting all the patients admitted in
their unit in an order beginning from intensive care
unit.
Here also there is documented case reports to
remind the case history of the patients who quickly
updates and is able to change the strategies of
treatments.
The ward team comprises of doctors,
nurses and pharmacists who work in a
team with a common objective to ensure
safe, effective, economic and patient
friendly treatment with knowledge inputs
of each professional practice.
The pharmacist being an expert in the matters of drug
should be available for the ward round team to decide
upon the matters of dosage regimens, formulary
interpretations, ADR monitoring, Drug-drug interactions,
Drug-food interactions and drug and poison information
services.
The availability of pharmaceutical services definitely
enhances accuracy of treatment, patient safety and
efficacy.
The pharmacist in ward round should take to 2 times one with the
doctors and another one with himself alone.
In the first ward round he follows the treatment given and checks the
formulary for the dose prescribed.
Further he may also critically think any possible risk to the patients due
to drug administered he will alert the team and prevents the further
causality that would have occurred due to non-viability of clinical
pharmacy services.
In the 2nd round the pharmacist targets the patients prior to discharge
and advice the patients regarding discharged medication practice in the
rounds. He also motivates to knowledge diet and exercise required for
disease management for a patient to be discharged.
The withdrawal of pharmacists from the ward rounds
will be a great loss for the clinical team and the
patients. The medication errors, incorrect dosage can
bring down the therapeutic outcomes in a negative
perspectives.
It is well established that the expectations from the
patients does not stop at the clinical cure but for a
cost effective economic expenses with improved
quality of life.
The gaps in the knowledge of healthcare practice in
disease management can be fulfilled by a qualified
pharmacist in a hospital.
Drug therapy monitoring, also known as Therapeutic
Drug Monitoring (TDM), is a means of monitoringdrug
levels in the blood.
Therapeutic drug monitoring (TDM) refers to the
measurement and interpretation of principally blood or
plasma drug concentration measurements with the
purpose of optimising a patients drug therapy and
clinical outcome while minimising the risk of drug-
induced toxicity.
TDM involves tailoring a dose regimen to an individual
patient by maintaining the plasma or blood
concentration within a particular range.
• To attain desired pharmacological effect of the drug.
• To reach the maximal effect in shortest possible time.
• To decrease the risk of toxicity.
• With a narrow therapeutic index.
• Which are highly protein bound.
• Which are liable to interact.
• In which the metabolite might be toxic.
MEDICATION CHART REVIEW
•It is a fundamental responsibility of a
pharmacist to ensure the appropriateness of
medication orders.
•It serves as starting point for other clinical
pharmacy activities ( medication counselling,
TDM, DI, and ADR).
•Organising information according to medical
problems ( example disease) helps breakdown a
complex situation into its individual parts.
GOALS:
1. To optimise the patients drug therapy.
2.To prevent or minimise drug related
problems/medication errors.
PROCEDURE:
√ The patients medical record should be reviewed in
conjugation with the medication administration
record.
√ Recent consultations, treatment plans and daily
progress should be taken into account when
determining the appropriateness of current
medication orders and planning each patient’s care.
√ All current and recent medication orders should be
reviewed.
1.
2.
3.
4.
c)
Checking that medication order is written in accordance
with legal and local requirements.
Ensuring that the medication order is comprehensible and
unambiguous, that appropriate terminology is used and that
drug name are not abbreviated. Annotate the chart to
provide clarification as required.
Detecting orders for medication to which the patient may be
hypersensitive/intolerant.
Ensuring that medication order is appropriate with respect
to:
a) The patient’s previous medication order.
b) Patient’s specific considerations e.g disease state,
pregnancy.
Drug dose and dosage schedule, especially with respect
to age, renal function, liver function.
d) Route, dosage form and method of administration.
5.Checking complete drug profile for medication
duplication,interactions or incompatibilities.
6.Ensuring that administration times are appropriate e.g.
with respect to food,other drugs and procedures.
7. Checking the medication administration record to
ensure that all ordered have been administered.
1.Ensuring that the drug administration order clearly indicates
the time at which drug administration is to commence.
2.Special considerations should be given especially in short
course
therapy as in antibiotics and analgesics.
1. Ensuring that the order is cancelled in all sections of
medication administration record when the drug therapy is
intended to cease.
2. If appropriate follow up of any non-formulary drug orders,
recommending a formulary equivalent if required.
1.Ensuring appropriate therapy monitoring is
implemented.
2.Ensuring that all necessary medication is ordered.
E.g. premedication, prophylaxis.
1. Reviewing medication for cost effectiveness.
2. Identification of drug related problems.
• Untreated indication.
• Inappropriate drug selection.
• Adverse drug reaction.
• Failure to receive drug.
• Drug interactions.
• Drug use without indication.
• Overdosage.
Medication chart Endorsement
Another important goal of treatment chart review is to
minimise the risk of medication errors that might
occur at the level of prescribing and / or drug
administration.
A medication error is any preventable error that may
lead to inappropriate medication use or patient harm.
To prevent potential morbidity and mortality
associated with these errors, pharmacists should
systematically review the medication chart and write
annotations on the chart where the medication orders
are unclear.
CLINICAL REVIEW
• Clinical review is one of the integral components of
medication review and should preferably be performed
on a daily basis. It is the review of the patients’progress
for the purpose of assessing the therapeutic outcome.
The therapeutic goal for the specific disease should be
clearly identified before the review.
:
The primary aims of the clinical review areto:
• Assess the response to drug treatment.
• Evaluate the safety of the treatment regimen.
• Assess the progress of the disease and the need forany
change in therapy.
• Assess the need for monitoring, if any. Assessthe
convenience of therapy(to improve compliance).
1. G. Parthasarathi, Karin Nyfort Hansen, Milap C Nahata.
A textbook of clinical pharmacy practice Essential
concepts and skills. Universities Press. 2nd edition.
2. A Text book of Pharmacy Practice by the author Sourabh
Kosey Nirali Prakashan. Page No.17.1-17.16
3. A Text book of Pharmacy Practice by the author Dr.
Sachin V. Tembhurne, Dr. Ashwini R. Madgulkar, Dr.
Virendra S. Ligade Nirali Prakashan. Page No.17.1-17.12
4. www.google.com
REFERENCES:-
Clinical Pharmacy

More Related Content

What's hot

03 investigational use drugs update from guidelines
03 investigational use drugs update from guidelines03 investigational use drugs update from guidelines
03 investigational use drugs update from guidelines
Sohani Ali
 

What's hot (20)

03 investigational use drugs update from guidelines
03 investigational use drugs update from guidelines03 investigational use drugs update from guidelines
03 investigational use drugs update from guidelines
 
Over the counter (OTC) sales
Over the counter (OTC) salesOver the counter (OTC) sales
Over the counter (OTC) sales
 
Investigational use of drugs
Investigational use of drugsInvestigational use of drugs
Investigational use of drugs
 
Drug information and poison information
Drug information and poison informationDrug information and poison information
Drug information and poison information
 
hospital formulary
hospital formularyhospital formulary
hospital formulary
 
Role of clinical pharmacist in dic
Role of clinical pharmacist in dicRole of clinical pharmacist in dic
Role of clinical pharmacist in dic
 
Pharmacy and therapeutic committee
Pharmacy and therapeutic committeePharmacy and therapeutic committee
Pharmacy and therapeutic committee
 
Package Insert
Package InsertPackage Insert
Package Insert
 
Introduction to clinical pharmacy
Introduction to clinical pharmacyIntroduction to clinical pharmacy
Introduction to clinical pharmacy
 
Clinical Pharmacy
Clinical PharmacyClinical Pharmacy
Clinical Pharmacy
 
Pharmacy and Therapeutic Committee
Pharmacy and Therapeutic CommitteePharmacy and Therapeutic Committee
Pharmacy and Therapeutic Committee
 
Ward round participation
Ward round participationWard round participation
Ward round participation
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
 
Drug distribution system in Hospital
Drug distribution system in HospitalDrug distribution system in Hospital
Drug distribution system in Hospital
 
Drug information final
Drug information finalDrug information final
Drug information final
 
Drug Information Services
Drug Information ServicesDrug Information Services
Drug Information Services
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
 
Retail pharmacy
Retail pharmacyRetail pharmacy
Retail pharmacy
 
Drug distribution system in a hospital.pptx
Drug distribution system in a hospital.pptxDrug distribution system in a hospital.pptx
Drug distribution system in a hospital.pptx
 
Patient counselling clinical pharmacy
Patient counselling clinical pharmacyPatient counselling clinical pharmacy
Patient counselling clinical pharmacy
 

Similar to Clinical Pharmacy

clinical pharmacy .pptx
clinical pharmacy .pptxclinical pharmacy .pptx
clinical pharmacy .pptx
AjithJs2
 
Drug_Utilization_Review.ppt
Drug_Utilization_Review.pptDrug_Utilization_Review.ppt
Drug_Utilization_Review.ppt
ashfaq22
 
Spontaneous reporting schemes for biodrug adverse reactions,
Spontaneous reporting schemes for biodrug adverse reactions,Spontaneous reporting schemes for biodrug adverse reactions,
Spontaneous reporting schemes for biodrug adverse reactions,
Vishwajeet Upadhye
 

Similar to Clinical Pharmacy (20)

Clinical pharmacy services
Clinical pharmacy services Clinical pharmacy services
Clinical pharmacy services
 
b. Clinical Pharmacy.pptx
b. Clinical Pharmacy.pptxb. Clinical Pharmacy.pptx
b. Clinical Pharmacy.pptx
 
RDP-CP-PP.pdf
RDP-CP-PP.pdfRDP-CP-PP.pdf
RDP-CP-PP.pdf
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
 
Clinical pharmacy ppt
Clinical pharmacy pptClinical pharmacy ppt
Clinical pharmacy ppt
 
clinical pharmacy .pptx
clinical pharmacy .pptxclinical pharmacy .pptx
clinical pharmacy .pptx
 
CLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptxCLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptx
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
Drug Utilization review
Drug Utilization review Drug Utilization review
Drug Utilization review
 
Drug_Utilization_Review.ppt
Drug_Utilization_Review.pptDrug_Utilization_Review.ppt
Drug_Utilization_Review.ppt
 
Clinical pharmacy recent advances
Clinical pharmacy recent advances Clinical pharmacy recent advances
Clinical pharmacy recent advances
 
ClinPhar-MODULE-2.pdf
ClinPhar-MODULE-2.pdfClinPhar-MODULE-2.pdf
ClinPhar-MODULE-2.pdf
 
Drug Therapy Monitoring
Drug Therapy MonitoringDrug Therapy Monitoring
Drug Therapy Monitoring
 
Clinical Pharmacy (CP)
Clinical Pharmacy (CP)Clinical Pharmacy (CP)
Clinical Pharmacy (CP)
 
General Discussion on Clinical Pharmacy
General Discussion on Clinical Pharmacy  General Discussion on Clinical Pharmacy
General Discussion on Clinical Pharmacy
 
Drug utilization review 1
Drug utilization review 1Drug utilization review 1
Drug utilization review 1
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
 
medication adherence.pdf
medication adherence.pdfmedication adherence.pdf
medication adherence.pdf
 
Spontaneous reporting schemes for biodrug adverse reactions,
Spontaneous reporting schemes for biodrug adverse reactions,Spontaneous reporting schemes for biodrug adverse reactions,
Spontaneous reporting schemes for biodrug adverse reactions,
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptx
 

More from sunayanamali

More from sunayanamali (20)

1. Introduction to Pharmaceutical Inorganic Chemistry
1. Introduction to Pharmaceutical Inorganic Chemistry1. Introduction to Pharmaceutical Inorganic Chemistry
1. Introduction to Pharmaceutical Inorganic Chemistry
 
PHARMACEUTICAL INORGANIC CHEMISTRY SYLLABUS COPY.pptx
PHARMACEUTICAL INORGANIC CHEMISTRY SYLLABUS COPY.pptxPHARMACEUTICAL INORGANIC CHEMISTRY SYLLABUS COPY.pptx
PHARMACEUTICAL INORGANIC CHEMISTRY SYLLABUS COPY.pptx
 
Pharmacy Practice Syllabus Copy
Pharmacy Practice Syllabus CopyPharmacy Practice Syllabus Copy
Pharmacy Practice Syllabus Copy
 
Warehousing and material management
Warehousing and material managementWarehousing and material management
Warehousing and material management
 
Equipments And Raw Material
Equipments And Raw MaterialEquipments And Raw Material
Equipments And Raw Material
 
Organization and personnel
Organization and personnelOrganization and personnel
Organization and personnel
 
NABL accreditation
NABL accreditation NABL accreditation
NABL accreditation
 
ISO 9000 & ISO14000
ISO 9000 & ISO14000ISO 9000 & ISO14000
ISO 9000 & ISO14000
 
Quality by design (QbD)
Quality by design (QbD)Quality by design (QbD)
Quality by design (QbD)
 
ICH Guidelines
ICH GuidelinesICH Guidelines
ICH Guidelines
 
Total Management (TQM)
Total Management (TQM) Total Management (TQM)
Total Management (TQM)
 
Quality Assurance and Quality Management concepts
Quality Assurance and Quality Management conceptsQuality Assurance and Quality Management concepts
Quality Assurance and Quality Management concepts
 
Syllabus Copy
Syllabus CopySyllabus Copy
Syllabus Copy
 
Effective Written Communication
Effective Written CommunicationEffective Written Communication
Effective Written Communication
 
Writing Effectively
Writing EffectivelyWriting Effectively
Writing Effectively
 
Group Discussion
Group DiscussionGroup Discussion
Group Discussion
 
Giving Presentations
Giving PresentationsGiving Presentations
Giving Presentations
 
Interview Skills
Interview SkillsInterview Skills
Interview Skills
 
Communication Styles
Communication StylesCommunication Styles
Communication Styles
 
Elements of Communication
Elements of CommunicationElements of Communication
Elements of Communication
 

Recently uploaded

Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
EADTU
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
AnaAcapella
 

Recently uploaded (20)

Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx
 
Our Environment Class 10 Science Notes pdf
Our Environment Class 10 Science Notes pdfOur Environment Class 10 Science Notes pdf
Our Environment Class 10 Science Notes pdf
 
Simple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdfSimple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdf
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
 
VAMOS CUIDAR DO NOSSO PLANETA! .
VAMOS CUIDAR DO NOSSO PLANETA!                    .VAMOS CUIDAR DO NOSSO PLANETA!                    .
VAMOS CUIDAR DO NOSSO PLANETA! .
 
Introduction to TechSoup’s Digital Marketing Services and Use Cases
Introduction to TechSoup’s Digital Marketing  Services and Use CasesIntroduction to TechSoup’s Digital Marketing  Services and Use Cases
Introduction to TechSoup’s Digital Marketing Services and Use Cases
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
Tatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsTatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf arts
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
dusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learningdusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learning
 

Clinical Pharmacy

  • 1. Clinical Pharmacy  Prepared By:-Ms.Mali Sunayana  Asst.Professor  Sahyadri College of Pharmacy, Methwade
  • 2. The pharmacy services can be broadly classified as clinical, hospital and community pharmacy services based on the point of service. The clinical pharmacy servicesare rendered in a clinic for inpatients and OPD patients. The inpatient services comprise of entire patient careand supplies regarding the aspects involving drugs. For example the activities like ward rounds ,safety,drug information services, poison centre, pharmacovigilance services, development and management of hospital formulary, patient counseling and education along with discharge medication.
  • 3. Ward round participation Ward rounds are the routine clinical roundswhere the healthcare providers visit the patients in the ward to assess the progress of the health condition of the inpatients. The doctor led ward rounds comprises of the unit of medicine or any other specialty where in professor,associate professors, assistant professors, senior residents, postgraduates and interns along with pharmacists and nurses observe the patient's condition nda assess to decide further therapeutics for the patients.
  • 4. The goal of the ward round is to closely monitor the patient's condition and take immediate intervention to improve the patient condition and avoid death. The doctors are visiting all the patients admitted in their unit in an order beginning from intensive care unit. Here also there is documented case reports to remind the case history of the patients who quickly updates and is able to change the strategies of treatments.
  • 5. The ward team comprises of doctors, nurses and pharmacists who work in a team with a common objective to ensure safe, effective, economic and patient friendly treatment with knowledge inputs of each professional practice.
  • 6. The pharmacist being an expert in the matters of drug should be available for the ward round team to decide upon the matters of dosage regimens, formulary interpretations, ADR monitoring, Drug-drug interactions, Drug-food interactions and drug and poison information services. The availability of pharmaceutical services definitely enhances accuracy of treatment, patient safety and efficacy.
  • 7. The pharmacist in ward round should take to 2 times one with the doctors and another one with himself alone. In the first ward round he follows the treatment given and checks the formulary for the dose prescribed. Further he may also critically think any possible risk to the patients due to drug administered he will alert the team and prevents the further causality that would have occurred due to non-viability of clinical pharmacy services. In the 2nd round the pharmacist targets the patients prior to discharge and advice the patients regarding discharged medication practice in the rounds. He also motivates to knowledge diet and exercise required for disease management for a patient to be discharged.
  • 8. The withdrawal of pharmacists from the ward rounds will be a great loss for the clinical team and the patients. The medication errors, incorrect dosage can bring down the therapeutic outcomes in a negative perspectives. It is well established that the expectations from the patients does not stop at the clinical cure but for a cost effective economic expenses with improved quality of life. The gaps in the knowledge of healthcare practice in disease management can be fulfilled by a qualified pharmacist in a hospital.
  • 9. Drug therapy monitoring, also known as Therapeutic Drug Monitoring (TDM), is a means of monitoringdrug levels in the blood. Therapeutic drug monitoring (TDM) refers to the measurement and interpretation of principally blood or plasma drug concentration measurements with the purpose of optimising a patients drug therapy and clinical outcome while minimising the risk of drug- induced toxicity. TDM involves tailoring a dose regimen to an individual patient by maintaining the plasma or blood concentration within a particular range.
  • 10. • To attain desired pharmacological effect of the drug. • To reach the maximal effect in shortest possible time. • To decrease the risk of toxicity. • With a narrow therapeutic index. • Which are highly protein bound. • Which are liable to interact. • In which the metabolite might be toxic.
  • 11. MEDICATION CHART REVIEW •It is a fundamental responsibility of a pharmacist to ensure the appropriateness of medication orders. •It serves as starting point for other clinical pharmacy activities ( medication counselling, TDM, DI, and ADR). •Organising information according to medical problems ( example disease) helps breakdown a complex situation into its individual parts.
  • 12. GOALS: 1. To optimise the patients drug therapy. 2.To prevent or minimise drug related problems/medication errors. PROCEDURE: √ The patients medical record should be reviewed in conjugation with the medication administration record. √ Recent consultations, treatment plans and daily progress should be taken into account when determining the appropriateness of current medication orders and planning each patient’s care. √ All current and recent medication orders should be reviewed.
  • 13. 1. 2. 3. 4. c) Checking that medication order is written in accordance with legal and local requirements. Ensuring that the medication order is comprehensible and unambiguous, that appropriate terminology is used and that drug name are not abbreviated. Annotate the chart to provide clarification as required. Detecting orders for medication to which the patient may be hypersensitive/intolerant. Ensuring that medication order is appropriate with respect to: a) The patient’s previous medication order. b) Patient’s specific considerations e.g disease state, pregnancy. Drug dose and dosage schedule, especially with respect to age, renal function, liver function. d) Route, dosage form and method of administration.
  • 14. 5.Checking complete drug profile for medication duplication,interactions or incompatibilities. 6.Ensuring that administration times are appropriate e.g. with respect to food,other drugs and procedures. 7. Checking the medication administration record to ensure that all ordered have been administered. 1.Ensuring that the drug administration order clearly indicates the time at which drug administration is to commence. 2.Special considerations should be given especially in short course therapy as in antibiotics and analgesics. 1. Ensuring that the order is cancelled in all sections of medication administration record when the drug therapy is intended to cease. 2. If appropriate follow up of any non-formulary drug orders, recommending a formulary equivalent if required.
  • 15. 1.Ensuring appropriate therapy monitoring is implemented. 2.Ensuring that all necessary medication is ordered. E.g. premedication, prophylaxis. 1. Reviewing medication for cost effectiveness. 2. Identification of drug related problems. • Untreated indication. • Inappropriate drug selection. • Adverse drug reaction. • Failure to receive drug. • Drug interactions. • Drug use without indication. • Overdosage.
  • 16. Medication chart Endorsement Another important goal of treatment chart review is to minimise the risk of medication errors that might occur at the level of prescribing and / or drug administration. A medication error is any preventable error that may lead to inappropriate medication use or patient harm. To prevent potential morbidity and mortality associated with these errors, pharmacists should systematically review the medication chart and write annotations on the chart where the medication orders are unclear.
  • 17. CLINICAL REVIEW • Clinical review is one of the integral components of medication review and should preferably be performed on a daily basis. It is the review of the patients’progress for the purpose of assessing the therapeutic outcome. The therapeutic goal for the specific disease should be clearly identified before the review. : The primary aims of the clinical review areto: • Assess the response to drug treatment. • Evaluate the safety of the treatment regimen. • Assess the progress of the disease and the need forany change in therapy. • Assess the need for monitoring, if any. Assessthe convenience of therapy(to improve compliance).
  • 18. 1. G. Parthasarathi, Karin Nyfort Hansen, Milap C Nahata. A textbook of clinical pharmacy practice Essential concepts and skills. Universities Press. 2nd edition. 2. A Text book of Pharmacy Practice by the author Sourabh Kosey Nirali Prakashan. Page No.17.1-17.16 3. A Text book of Pharmacy Practice by the author Dr. Sachin V. Tembhurne, Dr. Ashwini R. Madgulkar, Dr. Virendra S. Ligade Nirali Prakashan. Page No.17.1-17.12 4. www.google.com REFERENCES:-